Company research
Lifevantage Corp
CIK 849146Updated Sep 25, 2026
SecurityLFVN · NASDAQ · equity
Name history
LIFELINE THERAPEUTICS, INC. · through Dec 6, 2006YAAK RIVER RESOURCES INC · through Sep 28, 2004
LFVN price & chart
Loading TradingView…
NASDAQ:LFVN on TradingView ↗About the company
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics - the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the MindBody GLP-1 SystemÒ, the newest comprehensive gut activator from LoveBiome P84, the Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic and hydration energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
In the news
LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026 ↗
Recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 62,111,000Source | 71,958,000Source | 60,299,000Source | 66,123,000Source |
| Property, Plant and Equipment, NetUSD | 7,310,000Source | 6,207,000Source | 7,813,000Source | 9,086,000Source |
| GoodwillUSD | 465,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 3,058,000Source | 245,000Source | 323,000Source | 455,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 20,201,000Source | 16,886,000Source | 21,605,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,990,000Source | 3,294,000Source | 2,949,000Source | 1,612,000Source |
| Inventory, NetUSD | 16,167,000Source | 20,669,000Source | 15,055,000Source | 16,073,000Source |
| Assets, CurrentUSD | 38,297,000Source | 50,894,000Source | 37,646,000Source | 44,284,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,834,000Source | 6,095,000Source | 2,443,000Source | 4,753,000Source |
| Operating Lease, Right-of-Use AssetUSD | 6,715,000Source | 8,041,000Source | 9,569,000Source | 8,738,000Source |
| Other Assets, NoncurrentUSD | 637,000Source | 601,000Source | 680,000Source | 569,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 28,522,000Source | 37,317,000Source | 34,308,000Source | 31,474,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 1,000Source | 1,000Source | 1,000Source | 1,000Source |
| Retained Earnings (Accumulated Deficit)USD | -103,462,000Source | -104,147,000Source | -108,738,000Source | -98,305,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,874,000Source | -1,175,000Source | -1,916,000Source | -1,361,000Source |
| Stockholders' Equity Attributable to ParentUSD | 33,589,000Source | 34,641,000Source | 25,991,000Source | 34,649,000Source |
| Additional Paid in Capital, Common StockUSD | 138,924,000Source | 139,962,000Source | 136,644,000Source | 134,314,000Source |
| Liabilities and EquityUSD | 62,111,000Source | 71,958,000Source | 60,299,000Source | 66,123,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 20,227,000Source | 27,217,000Source | 22,309,000Source | 19,609,000Source |
| Operating Lease, Liability, CurrentUSD | 1,935,000Source | 1,867,000Source | 1,811,000Source | 1,521,000Source |
| Accounts Payable, CurrentUSD | 5,156,000Source | 4,600,000Source | 5,853,000Source | 3,505,000Source |
| Operating Lease, Liability, NoncurrentUSD | 7,933,000Source | 9,811,000Source | 11,801,000Source | 11,566,000Source |
| Other Liabilities, NoncurrentUSD | 362,000Source | 289,000Source | 198,000Source | 299,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 7,412,000Source | 13,513,000Source | 7,874,000Source | 7,932,000Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 2,773,000Source | 3,156,000Source | 3,581,000Source | 3,579,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,346,000Source | 5,702,000Source | 3,280,000Source | 3,188,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -200,000Source | 242,000Source | 1,424,000Source | -1,558,000Source |
| Increase (Decrease) in InventoriesUSD | -2,019,000Source | 5,216,000Source | -662,000Source | -61,000Source |
| Increase (Decrease) in Accounts PayableUSD | 588,000Source | -1,295,000Source | 2,301,000Source | -3,982,000Source |
| Deferred Income Tax Expense (Benefit)USD | 377,000Source | -1,686,000Source | -1,274,000Source | -1,675,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 10,241,000Source | 11,878,000Source | 12,197,000Source | 6,828,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -7,314,000Source | -1,367,000Source | -2,245,000Source | -3,059,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,571,000Source | 1,371,000Source | 2,245,000Source | 3,067,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 3,616,000Source | 2,664,000Source | 1,221,000Source | 201,000Source |
| Payments for Repurchase of Common StockUSD | 2,043,000Source | 3,147,000Source | 6,430,000Source | 822,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -7,783,000Source | -7,598,000Source | -14,417,000Source | -2,357,000Source |
| Dividends paid | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -5,281,000Source | 3,315,000Source | -4,719,000Source | 1,415,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 14,920,000Source | 20,201,000Source | 16,886,000Source | 21,605,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 11,000Source | 2,000Source | 21,000Source | 5,000Source |
| Income Taxes Paid, NetUSD | 995,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -425,000Source | 402,000Source | -254,000Source | 3,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 2,300,000Source | — | — | — |
| Amortization of Debt Issuance CostsUSD | — | 32,000Source | 7,000Source | — |
| Amortization of Intangible AssetsUSD | 400,000Source | 100,000Source | 100,000Source | 100,000Source |
| DepreciationUSD | 2,400,000Source | 3,100,000Source | 3,400,000Source | 3,400,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -200,000Source | -380,000Source | -429,000Source | -373,000Source |
| Gain (Loss) on Disposition of AssetsUSD | -7,000Source | — | — | — |
| Gain (Loss) on Sale of DerivativesUSD | — | — | — | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | 4,000Source | -2,000Source | -33,000Source |
| GoodwillUSD | 465,000Source | — | — | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 994,000Source | 2,438,000Source | 1,413,000Source | 1,459,000Source |
| Inventory Write-downUSD | 2,721,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | 5,072,000Source | 9,805,000Source | 2,937,000Source | 2,540,000Source |
| Nonoperating Income (Expense)USD | -34,000Source | 44,000Source | 18,000Source | -260,000Source |
| Operating ExpensesUSD | 135,513,000Source | 171,467,000Source | 154,392,000Source | 165,752,000Source |
| Other Nonoperating Income (Expense)USD | -198,000Source | -387,000Source | -412,000Source | -458,000Source |
| Payments of Financing CostsUSD | 12,000Source | 0Source | 97,000Source | — |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 182,586,000Source | 228,530,000Source | 200,164,000Source | 213,398,000Source |
| Cost of RevenueUSD | 40,973,000Source | 44,864,000Source | 41,440,000Source | 43,387,000Source |
| Selling, General and Administrative ExpenseUSD | 58,419,000Source | 69,207,000Source | 68,472,000Source | 71,065,000Source |
| Operating Income (Loss)USD | 6,100,000Source | 12,199,000Source | 4,332,000Source | 4,259,000Source |
| Other Nonoperating Income (Expense)USD | -198,000Source | -387,000Source | -412,000Source | -458,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 6,066,000Source | 12,243,000Source | 4,350,000Source | 3,999,000Source |
| Income Tax Expense (Benefit)USD | 994,000Source | 2,438,000Source | 1,413,000Source | 1,459,000Source |
| Net Income (Loss) Attributable to ParentUSD | 5,072,000Source | 9,805,000Source | 2,937,000Source | 2,540,000Source |
| Earnings Per Share, BasicUSD per share | 0.4Source | 0.8Source | 0.24Source | 0.2Source |
| Earnings Per Share, DilutedUSD per share | 0.4Source | 0.75Source | 0.23Source | 0.2Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 12,534,000Source | 12,251,000Source | 12,458,000Source | 12,557,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 12,702,000Source | 12,987,000Source | 12,986,000Source | 12,567,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 400,000Source | 100,000Source | 100,000Source | 100,000Source |
| Current Income Tax Expense (Benefit)USD | 617,000Source | 4,124,000Source | 2,687,000Source | 3,134,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -200,000Source | -380,000Source | -429,000Source | -373,000Source |
| Gross ProfitUSD | 141,613,000Source | 183,666,000Source | 158,724,000Source | 170,011,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 4,971,000Source | 10,397,000Source | 2,940,000Source | 2,464,000Source |
| Interest ExpenseUSD | — | — | -430,000Source | -198,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | 164,000Source | — | — | — |
| Interest Revenue (Expense), NetUSD | — | 431,000Source | — | — |
| Nonoperating Income (Expense)USD | -34,000Source | 44,000Source | 18,000Source | -260,000Source |
| Operating ExpensesUSD | 135,513,000Source | 171,467,000Source | 154,392,000Source | 165,752,000Source |
| Research and Development ExpenseUSD | 1,000,000Source | 1,400,000Source | 700,000Source | 600,000Source |
Filing attachments
lfvn-ex99_1.htm · 8-K · 2026-08-27
EX-99.1 2 lfvn-ex99_1.htm EX-99.1 EX-99.1 LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026 Salt Lake City, UT, August 27, 2026, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026. Fourth Quarter Fiscal 2026 Summary*: • Revenue was $42.4 million, a decr…
Read attachment ↗lfvn-ex99_1.htm · 8-K · 2026-05-06
EX-99.1 2 lfvn-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026 Salt Lake City, UT, May 6, 2026, LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2026. Third Quarter Fiscal 2026 Summary*: • Revenue was $43.7 million, a decrease of 2…
Read attachment ↗lfvn-ex99_1.htm · 8-K · 2026-04-16
EX-99.1 4 lfvn-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 LifeVantage Appointing Terrence Moorehead as Chief Executive Officer Salt Lake City, UT, April 16, 2026, LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Terrence Moorehead as the Company’s new President and Chief Executive Officer and as a member of the Boa…
Read attachment ↗